+91-98 455 710 46 | info@nckpharma.com

Pharma News

Keep updating your pharma knowledge
24 Jun 2016

Sanaofi’s Dengvaxia got 5th country approval – Costa Rica

Sanofi Pasteur, Sanofi’s vaccine division, announced that the National Ministry of Health of Costa Rica has approved Sanofi Pasteur’s tetravalent dengue vaccine, Dengvaxia®, to protect individuals 9 to 45 years of age living in endemic areas against all four serotypes of dengue. This approval in Costa Rica is the fourth registration of the dengue vaccine in Latin America, and the fifth in the world.

Sanofi Pasteur’s dengue vaccine has already been approved in following countries –

  • Mexico
  • Brazil,
  • El Salvador
  • Philippines

Related Reading: Denguvaxia 1st regulatory approval. >> Read more

Leave a Reply

Scale up your Pharma knwledge to Next Level with our Free Content

Case studies & Caselets
Simulation based learning
Online self competency assessment tests